Piotr Radziwon, Piotr Rozentryt#, Tomasz Banasiewicz#, Paweł Derlatka, #, Ryszard Gellert#, Rafał Stec#, Grażyna Rydzewska-Wyszkowska#
Initial clinical and laboratory optimalization of the patient general health status before primary cancer treatment appears to be one of the key aspects in the management of malignancy and should be continued during cancer therapy.The purpose of this strategy is to prepare the patient for oncology treatment, secure its optimal tolerance, reduce risk of complications, and improve quality of life on every stage of cancer management.It can be achieved with dietary intervention, physiotherapy, psychology support, as well as comorbidity control, including iron deficiency, especially resulting in anemia.Appropriate laboratory investigations are essential and iron replenishment started if required.The aim of this position paper is to discuss principles of iron supplementation in this specific group of patients.